Free Trial

Titan Pharmaceuticals (TTNP) Earnings Date, Estimates & Call Transcripts

Titan Pharmaceuticals logo
$3.46 -0.38 (-9.90%)
As of 03:59 PM Eastern

Titan Pharmaceuticals Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 31Estimated
Actual EPS
(Jan. 3)
-$0.83 Missed By -$0.83

Titan Pharmaceuticals announced Q3 2024 earnings on January 3, 2025, reporting an EPS of -$0.83. Titan Pharmaceuticals currently has a trailing EPS of $0.00

TTNP Upcoming Earnings

Titan Pharmaceuticals' next earnings date is estimated for Monday, March 31, 2025, based off prior year's reporting schedules.

Get Titan Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Titan Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TTNP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TTNP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Titan Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/31/2025
(Estimated)
-------
1/3/2025Q3 2024--$0.83 -$0.83-$0.83--
8/15/2024Q2 2024--$2.29 -$2.29-$2.29--
5/15/2024Q1 2024--$1.24 -$1.24-$1.24--
11/14/2023Q3 2023--$0.40 -$0.40-$0.02--
8/14/2023Q2 2023--$2.20 -$2.20-$0.11-$0.08M
5/15/2023Q1 2023--$2.20 -$2.20-$2.20-$0.10M
3/31/2023Q4 2022--$3.40 -$3.40-$3.40-$0.12M


This page (NASDAQ:TTNP) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners